Latest News
FDA/CDC
FDA approves Diacomit for Dravet syndrome
Stiripentol (Diacomit) is a new way to treat this rare but potentially life-threatening form of epilepsy.
News from the FDA/CDC
Feds take baseline on EHR interoperability
Survey respondents report challenges with integrating external reports, summaries.
Guidelines
AAN and others update practice guidelines for prolonged disorders of consciousness
Conference Coverage
Migraine takes toll on intimate relationships
From the Journals
Opioids, other causes linked to shorter lifespans, rising midlife mortality
Life expectancy has dipped, and death rate for the 25-64 year age range is rising among multiple ethnic groups.
Conference Coverage
Spontaneous intracranial hypotension: a triple misnomer
SAN FRANCISCO – It’s not rare, either: Every headache specialist probably has unrecognized patients in their practice.
Conference Coverage
App tied to reducing insomnia, depression in adults
ROCKVILLE, MD. – ‘Sleepio,’ an online intervention, could address the shortage of clinicians equipped to use CBT to treat insomnia.
Managing Your Practice
Employment practices liability insurance
All EPLI policies cover litigation against your practice and its owners by employees, but some cover only full-time workers.
Feature
Docs push back on step therapy in Medicare Advantage
The action is part of the broader Trump administration initiative to lower the prices and out-of-pocket costs of prescription drugs.
Conference Coverage
French warn of upsurge in pneumococcal meningitis
MALMO, SWEDEN – Culprit is emergence of serotype 24F, not covered by PCV13.
From the Journals
TBI linked to increased suicide risk
The sheer size of the study and the length of follow-up are among the study’s many strengths.